Qualigen Therapeutics, Inc.

DB:7R9 Stock Report

Market Cap: €4.0m

Qualigen Therapeutics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Kevin Richardson

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure2.2yrs

Recent management updates

Recent updates


CEO

Kevin Richardson (56 yo)

less than a year

Tenure

Mr. Kevin A. Richardson, II, is Interim CEO, Interim CFO & Director of Qualigen Therapeutics, Inc. from September 26, 2024. Mr. Richardson had been the Chairman at SANUWAVE Health, Inc. since October 2009...


Leadership Team

NamePositionTenureCompensationOwnership
Michael Poirier
Chief Operating Officerno dataUS$632.70k0.078%
$ 3.1k
Kevin Richardson
Interim CEOless than a yearno datano data
Campbell Becher
President & Independent Directorless than a yearno datano data
Christopher Lotz
VP of Finance & Corporate Secretary1.8yrsUS$3.02m0.0046%
$ 185.2

0.08yrs

Average Tenure

57.5yo

Average Age

Experienced Management: 7R9's management team is not considered experienced ( 0.1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Kevin Richardson
Interim CEOless than a yearno datano data
Campbell Becher
President & Independent Directorless than a yearno datano data
Michael Gordon
Member of Scientific Advisory Board2.2yrsno datano data
Anthony Tolcher
Member of Scientific Advisory Board2.2yrsno datano data
Lillian Siu
Member of Scientific Advisory Board2.2yrsno datano data
Robert Lim
Independent Directorless than a yearno datano data
Wayne Klohs
Chair of Scientific Advisory Board2.2yrsno datano data
Matthew Korenberg
Independent Director4.4yrsUS$42.00k0%
$ 0
Patricia LoRusso
Member of Scientific Advisory Board2.2yrsno datano data
Christopher Slapak
Member of Scientific Advisory Board2.2yrsno datano data
Stephen Neidle
Member of Scientific Advisory Board2.2yrsno datano data
Cody Price
Independent Directorless than a yearno datano data

2.2yrs

Average Tenure

51yo

Average Age

Experienced Board: 7R9's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.